ArticleBrain and behavior2025
Causal Effects of Inflammatory Cytokines on Bipolar Disorder: A Bidirectional Two-Sample Mendelian Randomization Study.
Article in Brain and behavior, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Causal inference in psychiatric research: how to critically evaluate and interpret mendelian randomization studies.Molecular psychiatry · 2026Review
- Causal Effects of Inflammatory Cytokines on Bipolar Disorder: A Bidirectional Two-Sample Mendelian Randomization Study.Brain and behavior · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
introductionInflammatory cytokine disturbance is a prominent outcome of immune dysregulation, extensively documented in bipolar disorder (BD). However, observational studies have exhibited inconsistent findings, and the causal relationships between inflammatory factors and BD remain unclear. Hence, this study aimed to uncover the causality between circulating inflammatory cytokines and BD.
methodsIn the bidirectional Mendelian randomization (MR) analysis, two genetic instruments derived from a publicly available genomic dataset were utilized. Genetic variant data for 41 inflammatory cytokines were obtained from a meta-analysis of genome-wide association studies involving 8293 Finnish individuals. BD data included 41,917 cases and 371,549 controls from the Psychiatric Genomics Consortium Database. To estimate causal connections between inflammation cytokines and BD, we performed five methods: inverse variance weighting (IVW), MR-Egger, weighted median, simple mode, and weighted mode. Sensitivity analyses were conducted to evaluate robustness, including tests for heterogeneity, pleiotropy, and leave-one-out validation.
resultsIn the IVW approach, we identified significant associations between genetic liability to elevated levels of interleukin-17 (IL-17), macrophage inflammatory protein-1α (MIP-1α), and monocyte chemotactic protein 3 (MCP-3) with increased risk of developing BD (odds ratio [OR] = 1.119, 95% confidence interval [CI] = 1.021-1.226, p = 0.016; OR = 1.084, 95% CI = 1.002-1.174, p = 0.044; OR = 1.060, 95% CI = 1.001-1.122, p = 0.046, respectively). Across the various MR methods employed, the directions of causal inferences remained consistent. However, reverse MR analysis revealed no significant evidence for causal effects of genetic predisposition to BD on inflammatory cytokines.
conclusionOur findings provide robust genetic evidence supporting causal effects of elevated circulating inflammatory cytokines on BD, conferring a high susceptibility to BD. Our study emphasizes that interventions aimed at reducing peripheral inflammatory cytokine levels should be prioritized in BD management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.